View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Market Data
July 21, 2016

M&As this week: Hansa Medical, Qingdao Gon Technology

Biopharmaceutical company Hansa Medical AB has acquired Immago Biosystems Ltd, a therapeutic antibodies developer in glycobiology.

Biopharmaceutical company Hansa Medical AB, has acquired Immago Biosystems Ltd, a therapeutic antibodies developer in glycobiology.

Hansa Medical AB expects that the transaction will provide it with rights to cancer immunotherapy using antibody-modulating enzymes.

Qingdao Gon Technology has announced its plans to acquire an undisclosed pharmaceutical company.

The company expects the acquisition to cost them up to $26.59m.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Clinical Trials Arena